Future treatments for hereditary hemorrhagic telangiectasia

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Rendu-Osler syndrome, is a genetic vascular disorder affecting 1 in 5000–8000 individuals worldwide. This rare disease is characterized by various vascular defects including epistaxis, blood vessel dilations (telangiectasia) and arteriovenou...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Florian, Desroches-Castan, Agnès, Bailly, Sabine, Dupuis-Girod, Sophie, Feige, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945546/
https://www.ncbi.nlm.nih.gov/pubmed/31910860
http://dx.doi.org/10.1186/s13023-019-1281-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945546/
https://www.ncbi.nlm.nih.gov/pubmed/31910860
http://dx.doi.org/10.1186/s13023-019-1281-4

Ejemplares similares